January 2, 2026 · Form 4 insider transaction
STEELE GLENN JR MD PHD sold 12,000 shares of PTC Therapeutics Inc at $76.35 per share, a transaction worth $916.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.